{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:08:15Z","timestamp":1648757295674},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Renal Replacement Therapy"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1053\/jarr.2000.16272","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:46:10Z","timestamp":1030247170000},"page":"358-364","source":"Crossref","is-referenced-by-count":1,"title":["Vitamin D Therapy in Patients With Chronic Renal Disease: The Role of the Renal Dietitian"],"prefix":"10.1053","volume":"7","author":[{"given":"Rebecca","family":"Sadler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1053\/jarr.2000.16272_bib1","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1053\/ajkd.1998.v32.pm9808141","article-title":"Vitamin D analogues","volume":"32","author":"Brown","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.16272_bib2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","article-title":"Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure","volume":"56","author":"Rix","year":"1999","journal-title":"Kidney Int"},{"issue":"Supp13","key":"10.1053\/jarr.2000.16272_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ndt\/11.supp3.130","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"11","author":"Slatopolsky","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2000.16272_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0002-9629(15)40549-X","article-title":"The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure","volume":"317","author":"Slatopolsky","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1053\/jarr.2000.16272_bib5","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ki.1992.404","article-title":"Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients","volume":"42","author":"Gallieni","year":"1992","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2000.16272_bib6","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/ki.1994.223","article-title":"Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD","volume":"45","author":"Quarles","year":"1994","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2000.16272_bib7","first-page":"551A","article-title":"Hyperphosphatemia and not hypercalcemia is the major factor in the therapeutic failure of dialysis patients with hyperparathyroid bone disease","volume":"9","author":"Yudd","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2000.16272_bib8","first-page":"324","article-title":"Long-term high dose intravenous calcitriol therapy in end-stage renal disease patients with severe secondary hyperparathyroidism","volume":"43","author":"Dressler","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1053\/jarr.2000.16272_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000045373","article-title":"Hyperphosphatemia: A serious limiting factor preventing the possible benefit from intravenous calcitriol therapy","volume":"82","author":"Arik","year":"1999","journal-title":"Nephron"},{"key":"10.1053\/jarr.2000.16272_bib10","first-page":"822","article-title":"Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism","volume":"7","author":"Malberti","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2000.16272_bib11","first-page":"1","article-title":"The treatment of renal osteodystrophy: Optimizing outcomes","author":"Llach","year":"1997","journal-title":"Nephrology Exchange"},{"key":"10.1053\/jarr.2000.16272_bib12","first-page":"767","article-title":"Toward a new treatment paradigm for hyperphosphatemia in chronic renal disease","volume":"27","author":"Norris","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2000.16272_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.16272_bib14","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0272-6386(96)90363-7","article-title":"Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients","volume":"27","author":"Braun","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.16272_bib15","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/ndt\/14.9.2178","article-title":"Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease","volume":"14","author":"Marchais","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2000.16272_bib16","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/ndt\/14.9.2085","article-title":"Hyperphosphataemia-a silent killer of patients with renal failure?","volume":"14","author":"Amann","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2000.16272_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1079\/PNS19940063","article-title":"Seasonal variation in vitamin D","volume":"53","author":"Maxwell","year":"1994","journal-title":"Proc Nutr Soc"},{"issue":"Suppl 3","key":"10.1053\/jarr.2000.16272_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ndt\/11.supp3.153","article-title":"1 \u03b1-Hydroxyvitamin D2: A new look at an \u2018old\u2019 compound","volume":"11","author":"Coburn","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 2","key":"10.1053\/jarr.2000.16272_bib19","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1053\/ajkd.1998.v32.pm9808140","article-title":"Mechanism of vitamin D action and its regulation","volume":"32","author":"Dusso","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.16272_bib20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1046\/j.1523-1755.1999.0550031019.x","article-title":"Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure","volume":"55","author":"Ishimura","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2000.16272_bib21","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0272-6386(97)90459-5","article-title":"Hyperparathyroidism in the hemodialysis population: A survey of 612 patients","volume":"29","author":"Salem","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.16272_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","article-title":"Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure","volume":"56","author":"Rostand","year":"1999","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"10.1053\/jarr.2000.16272_bib23","first-page":"S38","article-title":"Renal bone disease-an ongoing challenge to the nephrologist","volume":"44","author":"Malluche","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1053\/jarr.2000.16272_bib24","doi-asserted-by":"crossref","first-page":"20472053","DOI":"10.1172\/JCI117890","article-title":"Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia","volume":"95","author":"Arnold","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1053\/jarr.2000.16272_bib25","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1046\/j.1523-1755.1999.00386.x","article-title":"Decreased calciumsensing receptor expression in hyperplastic parathyroid glands of uremic rats: Role of dietary phosphate","volume":"55","author":"Brown","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2000.16272_bib26","doi-asserted-by":"crossref","first-page":"14361443","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1053\/jarr.2000.16272_bib27","unstructured":"United States Renal System, 1998 Annual Data Report."},{"key":"10.1053\/jarr.2000.16272_bib28","doi-asserted-by":"crossref","first-page":"532539","DOI":"10.1016\/S0272-6386(12)80831-6","article-title":"Safety and efficacy of long-term treatment of secondary hyperparathyroidism by lowdose intravenous calcitriol","volume":"19","author":"Sprague","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.16272_bib29","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1681\/ASN.V251014","article-title":"The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients","volume":"2","author":"Rodriguez","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2000.16272_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1681\/ASN.V73488","article-title":"Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients","volume":"7","author":"Levine","year":"1996","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 3","key":"10.1053\/jarr.2000.16272_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ndt\/11.supp3.96","article-title":"Guidelines for dosing of intravenous calcitriol in dialysis patients with hyperparathyroidism","volume":"11","author":"Fernandez","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2000.16272_bib32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ajcn\/69.5.842","article-title":"Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety","volume":"69","author":"Vieth","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/jarr.2000.16272_bib33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1532-5415.1999.tb03001.x","article-title":"Secondary hyperparathyroidism in patients from Western Australia with hip fracture: Relationship to type of hip fracture, renal function, and vitamin D deficiency","volume":"47","author":"Bruce","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1053\/jarr.2000.16272_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.1997.39","article-title":"Effective suppression of parathyroid hormone by 1-\u03b1-hydroxyvitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism","volume":"51","author":"Tan","year":"1997","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"10.1053\/jarr.2000.16272_bib35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ndt\/13.suppl_3.68","article-title":"Intermittent oral 1-\u03b1-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients","volume":"13","author":"Frazao","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 2","key":"10.1053\/jarr.2000.16272_bib36","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1053\/ajkd.1998.v32.pm9808145","article-title":"Therapy of secondary hyperparathyroidism with 19-nor-l-\u03b1,25-dihydroxyvitamin D2","volume":"32","author":"Martin","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.16272_bib37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0006-2952(97)00004-X","article-title":"Pharmacokinetics and systemic effect on calcium homeostasis of 1-\u03b1,24-dihydroxyvitamin D2 in rats. Comparison with 1 \u03b1,25-dihydroxyvitamin D2, calcitriol, and calcipotriol","volume":"53","author":"Knutson","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/jarr.2000.16272_bib38","first-page":"2156","article-title":"Unique 24-hydroxylated metabolites represent a significant pathway of metabolism of vitamin D2 in humans: 24-hydroxyvitamin D2 and 1,24-dihydroxyvitamin D2 detectable in human serum","volume":"83","author":"Mawer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/jarr.2000.16272_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(97)90571-0","article-title":"A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content","volume":"30","author":"Takahashi","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.16272_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0002-9629(15)40553-1","article-title":"Prevention of renal osteodystrophy in predialysis patients","volume":"317","author":"Sanchez","year":"1999","journal-title":"Am J Med Sci"},{"issue":"Suppl 3","key":"10.1053\/jarr.2000.16272_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/ndt\/13.suppl_3.51","article-title":"Prevention, diagnosis and treatment of renal osteodystrophy in Spain. Preliminary results from a multicentre enquiry","volume":"13","author":"D\u00edaz-Corte","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl","key":"10.1053\/jarr.2000.16272_bib42","first-page":"S71","article-title":"Prevention of metabolic bone disease in the pre-end-stage renal disease setting","volume":"9","author":"Coburn","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1053\/jarr.2000.16272_bib43","first-page":"S3","article-title":"Pathogenic, clinical, and therapeutic aspects of secondary hyperparathyroidism in chronic renal failure","volume":"32","author":"Llach","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.16272_bib44","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0272-6386(97)90330-9","article-title":"The importance of dietary calcium and phosphorus in the secondary hyperparathyroidism of patients with early renal failure","volume":"29","author":"Martinez","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.16272_bib45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alf acalcidol on natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"BMJ"},{"key":"10.1053\/jarr.2000.16272_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1525-139X.1998.tb00363.x","article-title":"Current and future therapies for the medical management of secondary hyperparathyroidism","volume":"11","author":"Chertow","year":"1998","journal-title":"Semin Dial"},{"key":"10.1053\/jarr.2000.16272_bib47","first-page":"630","article-title":"Secondary hyperparathyroidism: Defining a model of optimal management","volume":"28","author":"Norris","year":"1999","journal-title":"Dial Transplant"},{"key":"10.1053\/jarr.2000.16272_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/039139889902200101","article-title":"Pathogenesis and treatment of secondary hyperparathyroidism in chronic renal disease","volume":"22","author":"Cannella","year":"1999","journal-title":"Int J Artif Organs"},{"issue":"Suppl 2","key":"10.1053\/jarr.2000.16272_bib49","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1053\/ajkd.1998.v32.pm9808143","article-title":"Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-Nor-1,25-dihydroxyvitamin D2","volume":"32","author":"Llach","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.16272_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0002-9629(15)40516-6","article-title":"Update on renal osteodystrophy: Pathogenesis and clinical management","volume":"317","author":"Sakhaee","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1053\/jarr.2000.16272_bib51","first-page":"309313","article-title":"A multidisciplinary approach to the control of the calcium X phosphate product in dialysis patients","volume":"28","author":"Hoar","year":"1999","journal-title":"Dial Transplant"},{"key":"10.1053\/jarr.2000.16272_bib52","first-page":"37","article-title":"Contracting with outpatient hemodialysis patients to improve adherence to treatment","volume":"26","author":"Laidlaw","year":"1999","journal-title":"ANNA J"},{"key":"10.1053\/jarr.2000.16272_bib53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1051-2276(99)90007-9","article-title":"Clinical outcome of calcitriol therapy and patient education program on hyperparathyroidism","volume":"9","author":"Poole","year":"1999","journal-title":"J Ren Nutr"}],"container-title":["Advances in Renal Replacement Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1073444900700574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1073444900700574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T05:35:27Z","timestamp":1621143327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1073444900700574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["S1073444900700574"],"URL":"https:\/\/doi.org\/10.1053\/jarr.2000.16272","relation":{},"ISSN":["1073-4449"],"issn-type":[{"value":"1073-4449","type":"print"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}